Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00VUT
|
|||
Former ID |
DNC013561
|
|||
Drug Name |
D-257C
|
|||
Synonyms |
D-257C; CHEMBL408950
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C28H31FN2O
|
|||
Canonical SMILES |
C1CC(N2CCN(C1C2)CC(C3=CC=C(C=C3)F)O)C(C4=CC=CC=C4)C5=CC=CC=C5
|
|||
InChI |
1S/C28H31FN2O/c29-24-13-11-21(12-14-24)27(32)20-30-17-18-31-19-25(30)15-16-26(31)28(22-7-3-1-4-8-22)23-9-5-2-6-10-23/h1-14,25-28,32H,15-20H2/t25-,26-,27-/m0/s1
|
|||
InChIKey |
FESQDZTUIIZPPV-QKDODKLFSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Further structural optimization of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine and 1,4-diazabicyclo[3.3.1]nonane derivatives by introducing an ex... Bioorg Med Chem. 2008 Mar 15;16(6):2769-78. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.